These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 12612647)

  • 1. Effect of pegylation on pharmaceuticals.
    Harris JM; Chess RB
    Nat Rev Drug Discov; 2003 Mar; 2(3):214-21. PubMed ID: 12612647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation--a well-proven strategy for the improvement of recombinant drugs.
    Zündorf I; Dingermann T
    Pharmazie; 2014 May; 69(5):323-6. PubMed ID: 24855821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegnology: a review of PEG-ylated systems.
    Bhadra D; Bhadra S; Jain P; Jain NK
    Pharmazie; 2002 Jan; 57(1):5-29. PubMed ID: 11836932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol).
    Zhang G; Han B; Lin X; Wu X; Yan H
    J Biochem; 2008 Dec; 144(6):781-8. PubMed ID: 18845567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Releasable PEGylation of proteins with customized linkers.
    Filpula D; Zhao H
    Adv Drug Deliv Rev; 2008 Jan; 60(1):29-49. PubMed ID: 17884239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstacles and pitfalls in the PEGylation of therapeutic proteins.
    Gaberc-Porekar V; Zore I; Podobnik B; Menart V
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):242-50. PubMed ID: 18283612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide bridge based PEGylation of proteins.
    Brocchini S; Godwin A; Balan S; Choi JW; Zloh M; Shaunak S
    Adv Drug Deliv Rev; 2008 Jan; 60(1):3-12. PubMed ID: 17920720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.
    An Q; Lei Y; Jia N; Zhang X; Bai Y; Yi J; Chen R; Xia A; Yang J; Wei S; Cheng X; Fan A; Mu S; Xu Z
    Biomol Eng; 2007 Dec; 24(6):643-9. PubMed ID: 18023612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product development issues for PEGylated proteins.
    Payne RW; Murphy BM; Manning MC
    Pharm Dev Technol; 2011 Oct; 16(5):423-40. PubMed ID: 20858059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns.
    Zhang X; Wang H; Ma Z; Wu B
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1691-702. PubMed ID: 25270687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.
    Parveen S; Sahoo SK
    Clin Pharmacokinet; 2006; 45(10):965-88. PubMed ID: 16984211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State of the art in PEGylation: the great versatility achieved after forty years of research.
    Pasut G; Veronese FM
    J Control Release; 2012 Jul; 161(2):461-72. PubMed ID: 22094104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period.
    Peleg-Shulman T; Tsubery H; Mironchik M; Fridkin M; Schreiber G; Shechter Y
    J Med Chem; 2004 Sep; 47(20):4897-904. PubMed ID: 15369394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapulmonary potential of polyethylene glycol-modified glucagon-like peptide-1s as a type 2 anti-diabetic agent.
    Lee KC; Chae SY; Kim TH; Lee S; Lee ES; Youn YS
    Regul Pept; 2009 Jan; 152(1-3):101-7. PubMed ID: 18951927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.